Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Sample Card Punching Workstation Provides High-Throughput Sample Prep

By BiotechDaily International staff writers
Posted on 22 Nov 2012
Image: The easyPunch STARlet workstation (Photo courtesy of Hamilton Robotics).
Image: The easyPunch STARlet workstation (Photo courtesy of Hamilton Robotics).
A new laboratory workstation has been developed to minimize human error and enables high-throughput sample preparation for a range of applications, such as forensic reference databasing as well as preclinical and clinical drug metabolism and pharmacokinetics (DMPK) and toxicology studies.

Hamilton Robotics (Reno, NV, USA) in collaboration with GE Healthcare (Chalfont St. Giles, UK) Life Sciences introduces the easyPunch STARlet workstation, the first fully automated system integrating sample card punching and liquid handling into one easy workflow.

The easyPunch STARlet system, made in Hamilton’s Bonaduz (Switzerland) facility, incorporates punching of GE Healthcare Whatman FTA and DMPK sample collection cards with automated sample extraction, eliminating typical logjams in laboratory processes.

“Because many labs lack a fully automated workflow, thousands of samples such as blood and saliva placed on punch cards are waiting long periods to be processed for critical studies and forensic analysis,” said Stefan Mauch, product manager of the easyPunch STARlet system. “Until now, sample card punching for analysis preparation required tedious manual work or separate semiautomated instruments and an operator. Researchers or technicians had to be consistently precise and experienced when handling and tracking samples, or the results could be compromised.”

The easyPunch workstation is based on the Hamilton Robotics Microlab STARlet platform and features two special modules and robotic arms for transporting and punching paper cards. The samples are monitored by effective tracking software to remove any risk of sample identification errors. The total process is tracked using imaging recognition. Hamilton’s proprietary software, based on industrial machine vision technology, provides complete control and monitoring of the punching process. The software recognizes the position and size of the card, identifies the sample by reading the barcode, and determines the punch area. The workstation also takes a picture of the target well to ensure the punch has arrived in the designated well.

Compatibility with library information-management systems (LIMS) and full traceability ensure that data can be linked effectively to each sample. The modular nature of the system enables incorporation of other devices, such as a centrifuge and a plate sealer, thus potentially integrating the entire workflow.

“Ease of use makes this workstation an attractive solution for repetitive tasks in forensic and biopharma sample handling,” remarked Navjot Kaur, product manager at Hamilton Robotics in Reno, Nevada. “Currently technicians manually clean between samples, but the easyPunch STARlet system performs this step automatically, reducing cross-contamination. Barcode reading and imaging support full traceability and reporting of samples, both during punching and downstream processing.”

Hamilton Company is a global leader in the development and manufacture of process measurement, liquid handling, robotics and storage solutions, serving customers in academic and private research laboratories, pharmaceutical, and clinical diagnostic companies and government institutions.

Related Links:

Hamilton Robotics
GE Healthcare




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A leukemia cell coated with antibody is marked for destruction by activated natural killer cells (Photo courtesy of the University of Southern California).

Leukemia Cells Are Killed in Culture by Immune Cells Grown from the Same Patient

Immune system natural killer (NK) cells were isolated from leukemia patients, expanded in culture, and then shown in an in vitro system to attack and destroy cancer cells from the original cell donors.... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.